Dr. Marie-Laure Yaspo
Co-founder and Chief Scientific Officer
Dr. Jan Mulder, holding a Master's in Neurobiology and a Ph.D. in Molecular Neurobiology, has had distinguished postdoc fellowships in Sweden and the UK, advancing his expertise in Neuroscience. His groundbreaking work in Aberdeen shed light on the endocannabinoid system's impact on Alzheimer’s. In 2004, he collaborated with the Human Protein Atlas project, yielding pivotal publications on the protein, secretagogin. By 2010, back in Sweden, Dr. Mulder was instrumental in launching an immunofluorescence facility at SciLifeLab. His dedication to the HPA project peaked in 2018 with significant research at Biomedicum, exploring mammalian brain protein expressions.